Align Technology (NASDAQ: ALGN) is a medical device company that designs, manufactures, and sells clear dental aligners and intraoral scanners. Revenue comes primarily from the sale of Invisalign clear aligner products to orthodontists and dentists, alongside sales of iTero intraoral scanning systems. The company operates globally, with customers across North America, Europe, and international markets. Align was incorporated and has its principal executive offices in the United States. The 10-K filed February 27, 2026 covers the fiscal year ended December 31, 2025. Product lines include Invisalign clear aligners and iTero scanners, serving dental and orthodontic professionals as the primary customer base. The business sells capital equipment in scanners and consumable-style treatment cases in aligners, creating a transactional revenue model tied to case volume submitted by doctors. Geographic and segment revenue breakdowns are not fully detailed in the available filing excerpts.
Invisalign clear aligners, iTero intraoral scanners. Additional products mentioned include other clear aligners and related dental products per the FY2025 10-K.
Transactional sales of Invisalign clear aligner cases submitted by orthodontist and dentist customers, plus capital equipment sales of iTero intraoral scanners. Revenue is case-volume driven on the aligner side and unit-sales driven on the scanner side.
Orthodontists and general practice dentists. End market is dental and orthodontic treatment for consumers. Customers are licensed dental professionals who submit cases and purchase scanning equipment.
Global operations including North America, Europe, and international markets. Operations and assets noted in Israel and Russia per FY2025 10-K risk disclosures.
Loading...